GRD Biotechnology Acquisition Limited (CGRD)
GRD Biotechnology Acquisition will go public soon, but the exact IPO date is still unknown.
IPO Price
$10.00
Shares Offered
4,000,000
Deal Size
$40.00M
Chart not available yet
Data will show when the stock starts trading.
| Market Cap | 70.00M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| Shares Out | 7.00M |
| EPS (ttm) | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Open | n/a |
| Previous Close | n/a |
| Day's Range | n/a |
| 52-Week Range | n/a |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About CGRD
GRD Biotechnology Acquisition Limited is a newly incorporated blank check company, incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. We intend to focus our search in the Asian biotechnology sector. [Read more]
Industry Shell Companies
Sector Financials
Founded 2023
Country China
Stock Exchange NASDAQ
Ticker Symbol CGRD
News
SPAC GRD Biotechnology Acquisition files for a $40 million IPO, targeting biotechs in Asia
GRD Biotechnology Acquisition, a blank check company targeting the biotech sector in Asia, filed on Wednesday with the SEC to raise up to $40 million in an initial public offering.
2 years ago - Renaissance Capital
New SPAC: GRD Biotechnology Acquisition Limited Files for $40M IPO
GRD Biotechnology (NASDAQ: CGRD) submitted its S-1 filing for a $40 million IPO this afternoon, marking the third SPAC to file in July.
2 years ago - SPACInsider
GRD Biotechnology Acquisition IPO Registration Document (S-1)
GRD Biotechnology Acquisition has filed to go public with an IPO on the NASDAQ.
2 years ago - SEC